−0.02GBP
−2.84 MGBP
132.06 KGBP
141.65 M
About SKINBIOTHERAPEUTICS PLC ORD GBP0.01
Sector
CEO
Stuart John Ashman
Headquarters
Newcastle-upon-Tyne
Website
Employees (FY)
11
Founded
2015
ISIN
GB00BF33H870
FIGI
BBG00G9CGL04
SkinBioTherapeutics Plc is a life science company, which focuses on skin health. It offers SkinBiotix, a technology platform based on microbiome research which comprises extracts of probiotic bacteria for skin application. The technology targets the following skin healthcare sectors: cosmetics, infection control, and eczema. The company was founded on June 10, 2015 is headquartered in Newcastle upon Tyne, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SBTX is 9.32 GBX — it has decreased by 4.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SKINBIOTHERAPEUTICS PLC ORD GBP0.01 stocks are traded under the ticker SBTX.
SKINBIOTHERAPEUTICS PLC ORD GBP0.01 is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
SBTX stock is 4.61% volatile and has beta coefficient of −1.48. Check out the list of the most volatile stocks — is SKINBIOTHERAPEUTICS PLC ORD GBP0.01 there?
One year price forecast for SKINBIOTHERAPEUTICS PLC ORD GBP0.01 has a max estimate of 0.48 GBX and a min estimate of 0.48 GBX.
SKINBIOTHERAPEUTICS PLC ORD GBP0.01 revenue for the last quarter amounts to 76.99 K GBX despite the estimated figure of 77.00 K GBX. In the next quarter revenue is expected to reach 107.00 K GBX.
Yes, you can track SKINBIOTHERAPEUTICS PLC ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
SBTX stock has fallen by 4.56% compared to the previous week, the month change is a 26.37% rise, over the last year SKINBIOTHERAPEUTICS PLC ORD GBP0.01 has showed a 45.18% decrease.
SBTX net income for the last quarter is −1.33 M GBP, while the quarter before that showed −1.55 M GBP of net income which accounts for 13.89% change. Track more SKINBIOTHERAPEUTICS PLC ORD GBP0.01 financial stats to get the full picture.
Today SKINBIOTHERAPEUTICS PLC ORD GBP0.01 has the market capitalization of 19.54 M, it has decreased by 12.48% over the last week.
No, SBTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SBTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SKINBIOTHERAPEUTICS PLC ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 11.00 employees. See our rating of the largest employees — is SKINBIOTHERAPEUTICS PLC ORD GBP0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SKINBIOTHERAPEUTICS PLC ORD GBP0.01 technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SKINBIOTHERAPEUTICS PLC ORD GBP0.01 stock shows the sell signal. See more of SKINBIOTHERAPEUTICS PLC ORD GBP0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SKINBIOTHERAPEUTICS PLC ORD GBP0.01 future price: according to them, SBTX price has a max estimate of 48.00 GBX and a min estimate of 48.00 GBX. Read a more detailed SKINBIOTHERAPEUTICS PLC ORD GBP0.01 forecast: see what analysts think of SKINBIOTHERAPEUTICS PLC ORD GBP0.01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SKINBIOTHERAPEUTICS PLC ORD GBP0.01 EBITDA is −2.96 M GBP, and current EBITDA margin is −2.24 K%. See more stats in SKINBIOTHERAPEUTICS PLC ORD GBP0.01 financial statements.